<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32747678</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>03</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients.</ArticleTitle><Pagination><StartPage>12998</StartPage><MedlinePgn>12998</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12998</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-69845-8</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease accompanied with severe paralysis or even death, while the pathogenesis of ALS is still unclear and no effective therapy exists. The accumulating evidence has indicated the association between gut microbiota and various neurological diseases. Thus, to explore the potential role of gut microbiome in ALS, 20 patients diagnosed with probable or definite ALS and 20 healthy controls were enrolled and their fecal excrements were collected. The analysis of fecal community diversity with 16S rDNA sequencing showed an obvious change in microbial structure of ALS patients, where Bacteroidetes at the phylum level and several microbes at the genus level were up-regulated, while Firmicutes at the phylum level and Megamonas at the genus level were down-regulated compared to healthy controls. Additionally, decreased gene function associated with metabolic pathways was observed in ALS patients. The metagenomics further demonstrated the discrepancies in microflora at the species level and relevant metabolites thereof were also revealed when combined with metabolomics. In conclusion, the altered composition of the gut microbiota and metabolic products in ALS patients provided deeper insights into the pathogenesis of ALS, and these biomarkers might be established as potential therapeutic targets which deserve further exploration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zeng</LastName><ForeName>Qianqian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Kaifu District, Changsha City, 410008, Hunan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Shen</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Traditional Chinese Medicine Hospital, Changde, 415000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Kangzhi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Eight-Year Program of Clinical Medicine, Xiangya School of Medicine, Central South University, Changsha, 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jinxia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Kaifu District, Changsha City, 410008, Hunan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Qiao</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Kaifu District, Changsha City, 410008, Hunan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Kaifu District, Changsha City, 410008, Hunan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Jiao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Kaifu District, Changsha City, 410008, Hunan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bi</LastName><ForeName>Fangfang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Kaifu District, Changsha City, 410008, Hunan Province, China. fangfangbi@csu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012336">RNA, Ribosomal, 16S</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D041963" MajorTopicYN="N">Bacteroidetes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055432" MajorTopicYN="N">Metabolomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012336" MajorTopicYN="N">RNA, Ribosomal, 16S</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32747678</ArticleId><ArticleId IdType="pmc">PMC7398913</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-69845-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-69845-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan MC, et al. Amyotrophic lateral sclerosis. Lancet (London, England) 2011;377:942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, et al. Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China. J. Neurol. Neurosurg. Psychiatry. 2015;86:1075&#x2013;1081. doi: 10.1136/jnnp-2015-310471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310471</ArticleId><ArticleId IdType="pubmed">26124198</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Cleveland DW. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou ZY, et al. Genetic epidemiology of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD. Edaravone: A new drug approved for ALS. Cell. 2017;171:725. doi: 10.1016/j.cell.2017.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.10.011</ArticleId><ArticleId IdType="pubmed">29100067</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. New Engl. J. Med. 1994;330:585&#x2013;591. doi: 10.1056/NEJM199403033300901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199403033300901</ArticleId><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang T, et al. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: A retrospective analysis of data from a dose-ranging study. Lancet Neurol. 2018;17:416&#x2013;422. doi: 10.1016/S1474-4422(18)30054-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30054-1</ArticleId><ArticleId IdType="pmc">PMC5899963</ArticleId><ArticleId IdType="pubmed">29525492</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal MK. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs. Med. Res. Rev. 2019;39:733&#x2013;748. doi: 10.1002/med.21528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21528</ArticleId><ArticleId IdType="pubmed">30101496</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson JK, et al. Host-gut microbiota metabolic interactions. Science (New York) 2012;336:1262&#x2013;1267. doi: 10.1126/science.1223813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1223813</ArticleId><ArticleId IdType="pubmed">22674330</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. CA-30, an oligosaccharide fraction derived from Liuwei Dihuang decoction, ameliorates cognitive deterioration via the intestinal microbiome in the senescence-accelerated mouse prone 8 strain. Aging (Albany NY) 2019;11:3463&#x2013;3486. doi: 10.18632/aging.101990.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101990</ArticleId><ArticleId IdType="pmc">PMC6594795</ArticleId><ArticleId IdType="pubmed">31160541</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharon G, et al. Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice. Cell. 2019;177:1600&#x2013;1618. doi: 10.1016/j.cell.2019.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.05.004</ArticleId><ArticleId IdType="pmc">PMC6993574</ArticleId><ArticleId IdType="pubmed">31150625</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin J, et al. Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack. J. Am. Heart Assoc. 2015 doi: 10.1161/JAHA.115.002699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.115.002699</ArticleId><ArticleId IdType="pmc">PMC4845212</ArticleId><ArticleId IdType="pubmed">26597155</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MJ, et al. Reproductive senescence and ischemic stroke remodel the gut microbiome and modulate the effects of estrogen treatment in female rats. Transl. Stroke Res. 2019 doi: 10.1007/s12975-019-00760-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12975-019-00760-5</ArticleId><ArticleId IdType="pubmed">31845185</ArticleId></ArticleIdList></Reference><Reference><Citation>Cignarella F, et al. Intermittent fasting confers protection in cns autoimmunity by altering the gut microbiota. Cell Metab. 2018;27:1222&#x2013;1235. doi: 10.1016/j.cmet.2018.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2018.05.006</ArticleId><ArticleId IdType="pmc">PMC6460288</ArticleId><ArticleId IdType="pubmed">29874567</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilton D, et al. Accumulation of alpha-synuclein in the bowel of patients in the pre-clinical phase of Parkinson's disease. Acta Neuropathol. 2014;127:235&#x2013;241. doi: 10.1007/s00401-013-1214-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1214-6</ArticleId><ArticleId IdType="pubmed">24240814</ArticleId></ArticleIdList></Reference><Reference><Citation>Aho VTE, et al. Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression. EBioMedicine. 2019;44:691&#x2013;707. doi: 10.1016/j.ebiom.2019.05.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.05.064</ArticleId><ArticleId IdType="pmc">PMC6606744</ArticleId><ArticleId IdType="pubmed">31221587</ArticleId></ArticleIdList></Reference><Reference><Citation>Camara-Lemarroy CR, Metz L, Meddings JB, Sharkey KA, Wee-Yong V. The intestinal barrier in multiple sclerosis: Implications for pathophysiology and therapeutics. Brain. 2018;141:1900&#x2013;1916. doi: 10.1093/brain/awy131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy131</ArticleId><ArticleId IdType="pmc">PMC6022557</ArticleId><ArticleId IdType="pubmed">29860380</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothhammer V, et al. Microglial control of astrocytes in response to microbial metabolites. Nature. 2018;557:724&#x2013;728. doi: 10.1038/s41586-018-0119-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0119-x</ArticleId><ArticleId IdType="pmc">PMC6422159</ArticleId><ArticleId IdType="pubmed">29769726</ArticleId></ArticleIdList></Reference><Reference><Citation>Cryan JF, O'Riordan KJ, Sandhu K, Peterson V, Dinan TG. The gut microbiome in neurological disorders. Lancet Neurol. 2020;19:179&#x2013;194. doi: 10.1016/S1474-4422(19)30356-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30356-4</ArticleId><ArticleId IdType="pubmed">31753762</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundu P, Blacher E, Elinav E, Pettersson S. Our gut microbiome: The evolving inner self. Cell. 2017;171:1481&#x2013;1493. doi: 10.1016/j.cell.2017.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.11.024</ArticleId><ArticleId IdType="pubmed">29245010</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y-G, et al. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin Ther. 2017;39:322&#x2013;336. doi: 10.1016/j.clinthera.2016.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2016.12.014</ArticleId><ArticleId IdType="pmc">PMC5344195</ArticleId><ArticleId IdType="pubmed">28129947</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E, et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 2019;572:474&#x2013;480. doi: 10.1038/s41586-019-1443-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId><ArticleId IdType="pubmed">31330533</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, et al. Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing. Front. Microbiol. 2016;7:1479. doi: 10.3389/fmicb.2016.01479.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.01479</ArticleId><ArticleId IdType="pmc">PMC5028383</ArticleId><ArticleId IdType="pubmed">27703453</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, et al. The fecal microbiome of ALS patients. Neurobiol. Aging. 2018;61:132&#x2013;137. doi: 10.1016/j.neurobiolaging.2017.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.09.023</ArticleId><ArticleId IdType="pubmed">29065369</ArticleId></ArticleIdList></Reference><Reference><Citation>Codagnone MG, et al. Programming bugs: Microbiota and the developmental origins of brain health and disease. Biol. Psychiatry. 2019;85:150&#x2013;163. doi: 10.1016/j.biopsych.2018.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2018.06.014</ArticleId><ArticleId IdType="pubmed">30064690</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K, et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat. Med. 2018;24:1579&#x2013;1589. doi: 10.1038/s41591-018-0140-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, et al. Amyotrophic lateral sclerosis&#x2014;a model of corticofugal axonal spread. Nat. Rev. Neurol. 2013;9:708&#x2013;714. doi: 10.1038/nrneurol.2013.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Veiga-Fernandes H, Mucida D. Neuro-immune interactions at barrier surfaces. Cell. 2016;165:801&#x2013;811. doi: 10.1016/j.cell.2016.04.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.04.041</ArticleId><ArticleId IdType="pmc">PMC4871617</ArticleId><ArticleId IdType="pubmed">27153494</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher E, Levy M, Tatirovsky E, Elinav E. Microbiome-modulated metabolites at the interface of host immunity. J. Immunol. 2017;198:572&#x2013;580. doi: 10.4049/jimmunol.1601247.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601247</ArticleId><ArticleId IdType="pubmed">28069752</ArticleId></ArticleIdList></Reference><Reference><Citation>Arumugam M, et al. Enterotypes of the human gut microbiome. Nature. 2011;473:174&#x2013;180. doi: 10.1038/nature09944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09944</ArticleId><ArticleId IdType="pmc">PMC3728647</ArticleId><ArticleId IdType="pubmed">21508958</ArticleId></ArticleIdList></Reference><Reference><Citation>Jandhyala SM, et al. Role of the normal gut microbiota. World J. Gastroenterol. 2015;21:8787&#x2013;8803. doi: 10.3748/wjg.v21.i29.8787.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v21.i29.8787</ArticleId><ArticleId IdType="pmc">PMC4528021</ArticleId><ArticleId IdType="pubmed">26269668</ArticleId></ArticleIdList></Reference><Reference><Citation>Visconti A, et al. Interplay between the human gut microbiome and host metabolism. Nat. Commun. 2019;10:4505. doi: 10.1038/s41467-019-12476-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12476-z</ArticleId><ArticleId IdType="pmc">PMC6776654</ArticleId><ArticleId IdType="pubmed">31582752</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Lin S, Zheng B, Cheung PCK. Short-chain fatty acids in control of energy metabolism. Crit. Rev. Food Sci. Nutr. 2018;58:1243&#x2013;1249. doi: 10.1080/10408398.2016.1245650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2016.1245650</ArticleId><ArticleId IdType="pubmed">27786539</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh A, et al. Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell. 2018 doi: 10.1016/j.cell.2018.09.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.09.055</ArticleId><ArticleId IdType="pubmed">30401435</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A, et al. Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase. Hum. Mol. Genet. 2015;24:7390&#x2013;7405. doi: 10.1093/hmg/ddv439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv439</ArticleId><ArticleId IdType="pmc">PMC4664174</ArticleId><ArticleId IdType="pubmed">26483191</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain A, Li XH, Chen WN. An untargeted fecal and urine metabolomics analysis of the interplay between the gut microbiome, diet and human metabolism in Indian and Chinese adults. Sci. Rep. 2019;9:9191. doi: 10.1038/s41598-019-45640-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-45640-y</ArticleId><ArticleId IdType="pmc">PMC6591403</ArticleId><ArticleId IdType="pubmed">31235863</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbohm A, et al. Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany. J. Neurol. 2018;265:774&#x2013;782. doi: 10.1007/s00415-018-8735-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8735-9</ArticleId><ArticleId IdType="pubmed">29392461</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L. The gut microbiota and obesity: From correlation to causality. Nat. Rev. Microbiol. 2013;11:639&#x2013;647. doi: 10.1038/nrmicro3089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro3089</ArticleId><ArticleId IdType="pubmed">23912213</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, Brown RH., Jr Finding a treatment for ALS&#x2014;will gene editing cut it? New Engl. J. Med. 2018;378:1454&#x2013;1456. doi: 10.1056/NEJMcibr1716741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr1716741</ArticleId><ArticleId IdType="pubmed">29641956</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrou P, et al. Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1/2 and 2a clinical trials. JAMA Neurol. 2016;73:337&#x2013;344. doi: 10.1001/jamaneurol.2015.4321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.4321</ArticleId><ArticleId IdType="pubmed">26751635</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, El Munsat TL. Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters W, et al. Improved bacterial 16S rRNA Gene (V4 and V4&#x2013;5) and fungal internal transcribed spacer marker gene primers for microbial community surveys. mSystems. 2016 doi: 10.1128/mSystems.00009-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSystems.00009-15</ArticleId><ArticleId IdType="pmc">PMC5069754</ArticleId><ArticleId IdType="pubmed">27822518</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravi RK, Walton K, Khosroheidari M. MiSeq: A next generation sequencing platform for genomic analysis. Methods Mol. Biol. 2018;1706:223&#x2013;232. doi: 10.1007/978-1-4939-7471-9_12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7471-9_12</ArticleId><ArticleId IdType="pubmed">29423801</ArticleId></ArticleIdList></Reference><Reference><Citation>Rognes T, Flouri T, Nichols B, Quince C, Mah&#xe9; F. VSEARCH: A versatile open source tool for metagenomics. PeerJ. 2016;4:e2584. doi: 10.7717/peerj.2584.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.2584</ArticleId><ArticleId IdType="pmc">PMC5075697</ArticleId><ArticleId IdType="pubmed">27781170</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaxter M, et al. Defining operational taxonomic units using DNA barcode data. Philos. Trans. R. Soc. Lond. Ser. B. Biol. Sci. 2005;360:1935&#x2013;1943. doi: 10.1098/rstb.2005.1725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2005.1725</ArticleId><ArticleId IdType="pmc">PMC1609233</ArticleId><ArticleId IdType="pubmed">16214751</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokulich NA, et al. Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat. Methods. 2013;10:57&#x2013;59. doi: 10.1038/nmeth.2276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2276</ArticleId><ArticleId IdType="pmc">PMC3531572</ArticleId><ArticleId IdType="pubmed">23202435</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporaso JG, et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods. 2010;7:335&#x2013;336. doi: 10.1038/nmeth.f.303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.f.303</ArticleId><ArticleId IdType="pmc">PMC3156573</ArticleId><ArticleId IdType="pubmed">20383131</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan K, et al. Distinct gut microbiota induced by different fat-to-sugar-ratio high-energy diets share similar pro-obesity genetic and metabolite profiles in prediabetic mice. mSystems. 2019 doi: 10.1128/mSystems.00219-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSystems.00219-19</ArticleId><ArticleId IdType="pmc">PMC6787563</ArticleId><ArticleId IdType="pubmed">31594827</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharpton TJ. An introduction to the analysis of shotgun metagenomic data. Front. Plant. Sci. 2014;5:209. doi: 10.3389/fpls.2014.00209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpls.2014.00209</ArticleId><ArticleId IdType="pmc">PMC4059276</ArticleId><ArticleId IdType="pubmed">24982662</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchfink B, Xie C, Huson DH. Fast and sensitive protein alignment using DIAMOND. Nat. Methods. 2015;12:59&#x2013;60. doi: 10.1038/nmeth.3176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3176</ArticleId><ArticleId IdType="pubmed">25402007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M, et al. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 2014;42:D199&#x2013;D205. doi: 10.1093/nar/gkt1076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt1076</ArticleId><ArticleId IdType="pmc">PMC3965122</ArticleId><ArticleId IdType="pubmed">24214961</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27&#x2013;30. doi: 10.1093/nar/28.1.27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/28.1.27</ArticleId><ArticleId IdType="pmc">PMC102409</ArticleId><ArticleId IdType="pubmed">10592173</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 2006;78:779&#x2013;787. doi: 10.1021/ac051437y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac051437y</ArticleId><ArticleId IdType="pubmed">16448051</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen B, Mei Z, Zeng C, Liu S. metaX: a flexible and comprehensive software for processing metabolomics data. BMC Bioinform. 2017;18:183. doi: 10.1186/s12859-017-1579-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-017-1579-y</ArticleId><ArticleId IdType="pmc">PMC5361702</ArticleId><ArticleId IdType="pubmed">28327092</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>